氨基端前腦鈉素(NT-ProBNP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)
High Sensitive ELISA Kit for N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP)
NT-Pro-BNP; ; N-BNP
- 編號(hào)HEA485Ra
- 物種Rattus norvegicus (Rat，大鼠)相同的名稱，不同的物種。
- 實(shí)驗(yàn)方法競(jìng)爭(zhēng)抑制
- 反應(yīng)時(shí)長(zhǎng)3h
- 檢測(cè)范圍24.69-2,000pg/mL
- 靈敏度最小可檢測(cè)劑量小于等于9.07pg/mL.
- 樣本類型serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 下載英文說(shuō)明書 中文說(shuō)明書
- 規(guī)格48T96T96T*596T*1096T*100
- 價(jià)格¥ 3158¥ 4512¥ 20304¥ 38352¥ 315840
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
實(shí)驗(yàn)結(jié)果圖
標(biāo)準(zhǔn)曲線圖
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
本試劑盒用于檢測(cè)氨基端前腦鈉素(NT-ProBNP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)，經(jīng)檢測(cè)與其它相似物質(zhì)無(wú)明顯交叉反應(yīng)。
由于受到技術(shù)及樣本來(lái)源的限制，不可能完成對(duì)所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測(cè)，因此本試劑盒有可能與未經(jīng)檢測(cè)的其它物質(zhì)有交叉反應(yīng)。
回收率
分別于定值血清及血漿樣本中加入一定量的氨基端前腦鈉素(NT-ProBNP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)（加標(biāo)樣品），重復(fù)測(cè)定并計(jì)算其均值，回收率為測(cè)定值與理論值的比率。
| 樣本 | 回收率范圍(%) | 平均回收率(%) |
| serum(n=5) | 82-101 | 89 |
| EDTA plasma(n=5) | 92-101 | 95 |
| heparin plasma(n=5) | 86-93 | 89 |
精密度
精密度用樣品測(cè)定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差：取同批次試劑盒對(duì)低、中、高值定值樣本進(jìn)行定量檢測(cè),每份樣本連續(xù)測(cè)定20 次，分別計(jì)算不同濃度樣本的平均值及SD值。
批間差：選取3個(gè)不同批次的試劑盒分別對(duì)低、中、高值定值樣本進(jìn)行定量測(cè)定，每個(gè)樣本使用同一試劑盒重復(fù)測(cè)定8次，分別計(jì)算不同濃度樣本的平均值及SD值。
批內(nèi)差： CV<10%
批間差： CV<12%
線性
在定值血清及血漿樣本內(nèi)加入適量的氨基端前腦鈉素(NT-ProBNP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)，并倍比稀釋成1:2，1:4，1:8，1:16的待測(cè)樣本，線性范圍即為稀釋后樣本中氨基端前腦鈉素(NT-ProBNP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)含量的測(cè)定值與理論值的比率。
| 樣本 | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 88-103% | 84-98% | 86-93% | 96-104% |
| EDTA plasma(n=5) | 81-101% | 96-103% | 84-95% | 98-105% |
| heparin plasma(n=5) | 85-95% | 95-105% | 99-105% | 87-94% |
穩(wěn)定性
經(jīng)測(cè)定，試劑盒在有效期內(nèi)按推薦溫度保存，其活性降低率小于5%。
為減小外部因素對(duì)試劑盒破壞前后檢測(cè)值的影響，實(shí)驗(yàn)室的環(huán)境條件需盡量保持一致，尤其是實(shí)驗(yàn)室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗(yàn)員來(lái)進(jìn)行操作可減少人為誤差。
實(shí)驗(yàn)流程
1. 實(shí)驗(yàn)前標(biāo)準(zhǔn)品、試劑及樣本的準(zhǔn)備；
2. 加樣（標(biāo)準(zhǔn)品及樣本）50µL，
加入50µL檢測(cè)液A(臨用前配制);
37°C溫育1小時(shí)。
3. 洗板3次；
4. 加檢測(cè)溶液B100µL，37°C孵育30分鐘；
5. 洗板5次；
6. 加TMB底物90µL，37°C孵育10-20分鐘；
7. 加終止液50µL，立即450nm讀數(shù)。
實(shí)驗(yàn)原理
本試劑盒應(yīng)用競(jìng)爭(zhēng)抑制酶聯(lián)免疫分析法測(cè)定標(biāo)本中待測(cè)物質(zhì)水平。將氨基端前腦鈉素(NT-ProBNP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)單克隆抗體包被微孔板，制成固相載體，往包被抗體的微孔中同時(shí)加入生物素標(biāo)記的抗原和待測(cè)抗原(標(biāo)準(zhǔn)品或樣本)，待測(cè)抗原與生物素標(biāo)記抗原對(duì)特異性抗體進(jìn)行競(jìng)爭(zhēng)結(jié)合。溫育后經(jīng)洗滌去掉未結(jié)合物，然后加入HRP標(biāo)記的親和素，經(jīng)過(guò)溫育和徹底洗滌后加入底物TMB顯色。TMB在過(guò)氧化物酶的催化下轉(zhuǎn)化成藍(lán)色，并在酸的作用下轉(zhuǎn)化成最終的黃色。待測(cè)標(biāo)本濃度越高，標(biāo)記抗原和抗體的結(jié)合就越受到抑制，顯色愈淺。顯色的深淺與酶量呈正相關(guān)，而與樣品中待測(cè)物質(zhì)含量呈負(fù)相關(guān)。用酶標(biāo)儀在450nm波長(zhǎng)下測(cè)定吸光度（O.D.值），計(jì)算樣品濃度。
贈(zèng)品
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Rattus norvegicus (Rat，大鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA485Ra01 | 氨基端前腦鈉素(NT-ProBNP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| CPA485Ra21 | 氨基端前腦鈉素(NT-ProBNP)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
| CPA485Ra22 | 氨基端前腦鈉素(NT-ProBNP)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
| CPA485Ra31 | 氨基端前腦鈉素(NT-ProBNP)鑰孔血藍(lán)蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
| PAA485Ra01 | 氨基端前腦鈉素(NT-ProBNP)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA485Ra08 | 氨基端前腦鈉素(NT-ProBNP)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA485Ra79 | 氨基端前腦鈉素(NT-ProBNP)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAA485Ra28 | 氨基端前腦鈉素(NT-ProBNP)單克隆抗體 | WB; IHC; ICC; IP. |
| SEA485Ra | 氨基端前腦鈉素(NT-ProBNP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| CEA485Ra | 氨基端前腦鈉素(NT-ProBNP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| HEA485Ra | 氨基端前腦鈉素(NT-ProBNP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA485Ra | 氨基端前腦鈉素(NT-ProBNP)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Eur Rev Med Pharmacol Sci. | The role of serum n-terminal pro-brain natriuretic peptide in transient tachypnea of the newborn[Europeanreview: Source] |
| Transplantation Proceedings | Vascular Adhesion Protein-1, a Novel Molecule, in Kidney and Heart Allograft Recipients[Pubmed: 23769096] |
| 34 | Paradoxical low-flow, low-gradient aortic stenosis despite preserved left ventricular ejection fraction: new insights from weights of operatively excised aortic valves[Pubmed: 24755006] |
| Integrative Medicine Insights | A Randomized Controlled Trial to Study the Effect of Yoga Therapy on Cardiac Function and N Terminal Pro BNP in Heart Failure[NCBI: PMC3981569] |
| Liver Int.? | Diabetes enhances the intrahepatic vascular response to endothelin-1 in cirrhotic rats: association with the ETA receptor and pERK up-regulation.[Pubmed:24636620] |
| Eur J Heart Fail. | Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.[Pubmed:24903195] |
| Scientific Reports | Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension[PubMed: 25747153] |
| Int J Mol Sci | The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension[PubMed: 25984599] |
| scientific reports | Effect of Treatment on Body Fluid in Patients with Unilateral Aldosterone Producing Adenoma: Adrenalectomy versus Spironolactone[PubMed: 26477337] |
| Liver Int | Diabetes enhances the intrahepatic vascular response to endothelin‐1 in cirrhotic rats: association with the ETA receptor and pERK up‐regulation[PubMed: 24636620] |
| Int J Clin Exp Pathol | Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction[PubMed: 26261541] |
| Iranian Journal of Pediatrics | NT-proBNP in Children With Left to Right Shunt and Dilated Cardiomyopathy[serve:4485] |
| International Journal of Cardiology | Human myoblast transplantation in mice infarcted heart alters the expression profile of cardiac genes associated with left ventricle remodeling[Pubmed:26457413] |
| IJC Heart & Vasculature | Cardiovascular changes in patients with non-severe Plasmodium vivax malaria[article:S2352-9067(16)30010-0] |
| Heart Lung Circ | Soluble Glycoprotein 130 and Heat Shock Protein 27 as Novel Candidate Biomarkers of Chronic Heart Failure with Preserved Ejection Fraction[Pubmed:27067668] |
| International journal of cardiology | Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies.[pubmed:27448535] |
| Experimental and Therapeutic Medicine | Expression of pericardial fluid T-cells and related inflammatory cytokines in patients with chronic heart failure.[pubmed:28565777] |
| Journal of Cardiovascular Electrophysiology | Effect of Cardiac Resynchronization Therapy on Myocardial Fibrosis and Relevant Cytokines in a Canine Model With Experimental Heart Failure.[pubmed:28127817] |
| Journal of Cardiovascular Ecography | Study of Vitamin D Status in Patients with Dilated Cardiomyopathy at a Teaching Hospital in North India.[pubmed:28465969] |
| International?Journal?of?Cardiology | 5-methoxytryptophan?is a?potential?marker?for?post-myocardial?infarction?heart?failure - apreliminary?approach?to?clinical?utility.[pubmed:27526355] |
| Cardiovasc Toxicol | Beneficial Effects of Ozone Therapy on Oxidative Stress, Cardiac Functions and Clinical Findings in Patients with Heart Failure Reduced Ejection Fraction[pubmed:28097518] |
| Sci Rep.? | Serial heart rhythm complexity changes in patients with anterior wall ST segment elevation myocardial infarction.[pubmed:28252107] |
| Journal of Cardiovascular Magnetic Resonance | The predictive capabilities of a novel cardiovascular magnetic resonance derived marker of cardiopulmonary reserve on established prognostic surrogate markers in patients with pulmonary vascular disease: results of a longitudinal pilot study[pubmed:28065166] |
| Repositório Institucional UNESP | AVALIA??O ELETROCARDIOGRáFICA AMBULATORIAL DE C?ES COM EHRLIQUIOSE MONOCíTICA CR?NICA[handle:11449] |
| Archivos de medicina veterinaria | Cardiac biomarkers in dogs with visceral leishmaniasis[S0301-732X2016000300004] |
| Original article | Evaluation of N-Terminal Pro Brain Natriuretic Peptide as a biomarker for clinical severity of heart failure in pediatric population[Attach432] |
| Evidence-Based Complementary and Alternative Medicine | Cardioprotection against Heart Failure by Shenfu Injection via TGF-β/Smads Signaling Pathway[pubmed:28698735] |
| Scientific Reports | QSKL protects against myocardial apoptosis on heart failure via PI3K/Akt-p53 signaling pathway.[pubmed:29209026] |
| Vascular Pharmacology | Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats[pubmed:29100963] |
| Evidence-based complementary and alternative medicine | Qiliqiangxin Enhances Cardiac Glucose Metabolism and Improves Diastolic Function in Spontaneously Hypertensive Rats[pubmed:28706558] |
| Europace | Prediction of electro-anatomical substrate using APPLE score and biomarkers[Pubmed:29893827] |
| Heart?Rhythm | Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes[Pubmed:29604419] |
| American Journal of Hypertension | MicroRNAs in Peripheral Mononuclear Cells as Potential Biomarkers in Hypertensive Patients With Heart Failure With Preserved Ejection Fraction[Pubmed:29506053] |
| International Journal of Molecular?Medicine | Differential microRNA expression profiles and bioinformatics analysis between young and aging spontaneously hypertensive rats[Pubmed:29328372] |
| Biomarkers | Regulation of circulating chromogranin B levels in heart failure[Pubmed:29098879] |
| Lung | Effect of 6-min Walk Test on pro-BNP Levels in Patients with Pulmonary Arterial Hypertension[Pubmed:29564533] |
| International Journal of Clinical and Exp Medicine | Dynamic monitoring the level of NT-proBNP in assessing the value of cardiac function and prognosis in patients with systemic infection[ijcem0072283.pdf] |
| FASEB?Journal | Signature-oriented investigation of the efficacy of multicomponent drugs against heart failure[Pubmed: 30230922] |
| International?Journal?of?Clinical?and?Experimental?Medicine | Qiliqiangxin ameliorates cardiac dysfunction in heart failure rats post myocardial infarction via activation of HIF/VEGF pathway[] |
| Pediatric?Hematology?Oncology?Journal | Decreasing cardiac iron overload with Amlodipine and Spirulina in children with β-thalassemia[Doi: 10.1016/j.phoj.2018.10.001] |
| Journal of?Clinical?Medicine | Acute Responses of Novel Cardiac Biomarkers to a 24-h Ultra-Marathon[Pubmed: 30625976] |
| Van Veterinary Journal | Relationship between Natriuretic Peptide Levels with Heart and Kidney Parameters in Rats with Chronic Renal Failure.[] |
| Journal of Complementary and Integrative?Medicine | Biological markers for the effects of yoga as a complementary and alternative medicine[Pubmed: 30735481] |
| Frontiers in Pharmacology | Trimetazidine Attenuates Exhaustive Exercise-Induced Myocardial Injury in Rats via Regulation of the Nrf2/NF-κB Signaling Pathway[Pubmed: 30890937] |
| Journal of Clinical Medicine | Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats[Pubmed: 31083544] |
| PLoS One | Evaluation of heart rate variability and behavior of electrocardiographic parameters in dogs affected by chronic Monocytic Ehrlichiosis[Pubmed: 31125348] |
| Cardiovascular Research | Cardio-protective effect of the secretome of Sca-1+ and Sca-1-cells in heart failure–not equal, but equally important? Paracrine cell effects on heart failure[] |
| Advances in Medical Sciences | The potential role of inflammation in cryptogenic stroke[] |
| Disease Markers | Arterial Stiffness and Indices of Left Ventricular Diastolic Dysfunction in Patients with Embolic Stroke of Undetermined Etiology[Pubmed: 31612072] |
| Journal of Human Kinetics | Hormonal Response to Incremental and Continuous Exercise in Cyclists with Left Ventricle Hypertrophy[Pubmed: 32148580] |
| Nature Communications | Preclinical development of a miR-132 inhibitor for heart failure treatment[Pubmed: 32005803] |
| MEDIATORS OF INFLAMMATION | Evaluating the Relationship of GDF-15 with Clinical Characteristics, Cardinal Features, and Survival in Multiple Myeloma[Pubmed: 33144847] |
| EUROPEAN HEART JOURNAL | CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure[Pubmed: 33089304] |
| REPRODUCTIVE TOXICOLOGY | Omega-3 polyunsaturated fatty acids alleviate hydrogen sulfide-induced blood-testis barrier disruption in the testes of adult mice[Pubmed: 33068716] |
| JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | Apela improves cardiac and renal function in mice with acute myocardial infarction[Pubmed: 32686917] |
| J Multidiscip Healthc | Left Ventricular Diastolic Dysfunction as Predictor of Unfavorable Prognosis After ESUS[33727824] |
| Oxid Med Cell Longev | κ Opioid Receptor Agonist Inhibits Myocardial Injury in Heart Failure Rats through Activating Nrf2/HO-1 Pathway and Regulating Ca2+-SERCA2a[34373768] |
| Biology | Hemodynamic Responses in Lower Limb Lymphedema Patients Undergoing Physical Therapy[34356497] |
| Arch Acad Emerg Med | Risk Stratification of Pulmonary Thromboembolism using Brain Natriuretic Peptide and Troponin I; a Brief Report[Pubmed:35072097] |
| Transl Res | Interplay between mineral bone disorder and cardiac damage in acute kidney injury: from Ca2+ mishandling and preventive role of Klotho in mice to its potential?…[Pubmed:35077866] |
| Medicina (Kaunas) | The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment[Pubmed:35334593] |
| Acta Cardiol Sin | Prothymosin α Gene Transfer Modulates Myocardial Remodeling after Ischemia-Reperfusion Injury[Pubmed:35273440] |
